Neurosearch AS said it has initiated phase I clinical studies of the drug candidate A
AFX News Limited
Neurosearch starts phase I study on drug as new Parkinson's disease treatment 12.18.07, 4:55 AM ET http://www.forbes.com/afxnewslimited...fx4451163.html COPENHAGEN (Thomson Financial) - Danish pharmaceutical company Neurosearch AS said it has initiated phase I clinical studies of the drug candidate ACR343 with a view to develop it as a new treatment for Parkinson's disease. 'This achievement further highlights the very satisfactory...development seen in the pipeline programmes we took over with the acquisition of Carlsson Research (now Neurosearch Sweden) in October 2006,' Neurosearch chief executive Flemming Pedersen said. As an effect of the study initiation, Neurosearch will make a 75 mln skr milestone payment to the former shareholders of Carlsson Research AB, the company said. Neurosearch reiterated its previous financial guidance for 2007 of a 230-250 mln dkr loss before recognition of associates and other equity interests. gustav.sandstrom@thomson.com |
Bogey
Hello, I'm new to your site. I'm 58 female and was diagnosed with PD in 2003 and doing pretty well so far. I'm interested in studies in the DC , Baltimore area. I do receive publications and read pdtrials.com. I belong to a local support group and start an exersise group for PD patients this week.I try to keep a positive outlook and make the best of each dayand some are better then others.
|
All times are GMT -5. The time now is 10:13 AM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.